Current understanding of SPEM and its standing in the preneoplastic process

Gastric Cancer

Volumn 12, Issue 4, 2009, Pages 189-197

  Weis, Victoria G ^a   Goldenring, James R ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gastric adenocarcinoma; Intestinal metaplasia; Metaplasia; SPEM

Indexed keywords

TREFOIL PEPTIDE; PEPTIDE; SPASMOLYTIC POLYPEPTIDE;

CANCER MORTALITY; CELL LINEAGE; CELL LOSS; CELL TRANSDIFFERENTIATION; CELL TRANSFORMATION; DISEASE MODEL; GERBIL; HELICOBACTER; HELICOBACTER FELIS; HELICOBACTER INFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CHIEF CELL; STOMACH PARIETAL CELL; ANIMAL; METABOLISM; METAPLASIA; MOUSE; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GERBILLINAE; HUMANS; METAPLASIA; MICE; PARIETAL CELLS, GASTRIC; PEPTIDES; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 77949906174     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-009-0527-6     Document Type: Review

References (66)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29. (Pubitemid 29409471)
2. Blaser M, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8. (Pubitemid 24218070)
3. Jain RN, Brunkan CS, Chew CS, Samuelson LC. Gene expression profiling of gastrin target genes in parietal cells. Physiol Genomics 2006;24:124-32.
4. Beauchamp RD, Barnard JA, McCutchen CM, Cherner JA, Coffey RJ Jr. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. J Clin Invest 1989;84:1017-23.
5. Murayama Y, Miyagawa JI, Higashiyama S, Kondo S, Yabu M, Kanayama S, et al. Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology 1995;109:1051-9.
6. Abe S, Sasano H, Katoh K, Ohara S, Arikawa T, Noguchi T, et al. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa. Dig Dis Sci 1997;42:1199-209. (Pubitemid 27343447)
7. Li Q, Karam SM, Gordon JI. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem 1996;271:3671-6. (Pubitemid 26065684)
8. El-Zimaity HMT, Ota H, Graham DY, Akamatsu T, Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 2002;94:1428-36. (Pubitemid 34212636)
9. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
10. Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V, Juersek A, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9. (Pubitemid 24168604)
11. Hattori T. Development of adenocarcinomas in the stomach. Cancer 1986;57:1528-34. (Pubitemid 16135598)
12. Takizawa T, Koike M. Minute gastric carcinoma from pathomorphological aspect - reconsideration concerning histogenesis of gastric carcinomas. Stomach and Intestine 1998;23:791-800.
13. Hattori T, Fujita S. Tritiated thymidine autotradiographic study on histogenesis and spreading of intestinal metaplasia in human stomach. Pathol Res Pract 1979;164:224-37. (Pubitemid 9210872)
14. Hattori T, Helpap B, Gedigk P. The morphology and cell kinetics of pseudopyloric glands. Virchows Arch B Cell Pathol Incl Mol Pathol 1982;39:31-40. (Pubitemid 12133306)
15. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Cheung K, et al. Antral-type mucosa in the gastric incisura, body and fundus (antralization) : a link between Helicobacter pylori infection and intestinal metaplasia. Am J Gastroenterol 2000;95:114-21. (Pubitemid 30041544)
16. Schmidt PH, Lee JR, Joshi V, Playford RJ, Poulsom R, Wright NA, et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999;79:639-46. (Pubitemid 29283417)
17. Yamaguchi H, Goldenring JR, Kaminishi M, Lee JR. Association of spasmolytic polypeptide expressing metaplasia (SPEM) with carcinogen administration and oxyntic atrophy in rats. Lab Invest 2002;82:1045-52.
18. Halldorsdottir AM, Sigurdardottir M, Jonasson JG, Oddsdottir M, Magnusson J, Lee JR, et al. Spasmolytic polypeptide expressing metaplasia (SPEM) associated with gastric cancer in Iceland Dig Dis Sci 2003;48:431-41. (Pubitemid 36324148)
19. Morson BC. Intestinal metaplasia of the gastric mucosa. Br J Cancer 1955;9:365-76.
20. Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986;10:1271-7. (Pubitemid 17219489)
21. Yamaguchi H, Goldenring JR, Kaminishi. M., Lee JR. Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci 2001;47:573-8. (Pubitemid 34218887)
22. Wang TC, Goldenring JR, Dangler C, Ito S, Mueller A, Jeon WK, et al. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 1998;114:675-89. (Pubitemid 28160402)
23. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, et al. Hypertrophic gastropathy in Helicobacter felis-infected wild type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996;110:155-66. (Pubitemid 26021615)
24. Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 2003;124:1879-90. (Pubitemid 36666783)
25. Nomura S, Yamaguchi H, Wang TC, Lee JR, Goldenring JR. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild type and gastrin deficient mice. Am J Physiol Gastrointest Liver Physiol 2004; 288: G362-75.
26. Goldenring JR, Ray GS, Coffey RJ, Meunier PC, Haley PJ, Barnes TB, et al. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology 2000;118:1080-93.
27. Fox JG, Blanco M, Murphy JC, Taylor NS, Lee A, Kabok Z, et al. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun 1993;61:2309-15. (Pubitemid 23159216)
28. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. I. Identification of proliferative cell types and pinpointing of the stem cells. Anat Rec 1993;236:259-79.
29. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. II. Outward migration of pit cells. Anat Rec 1993;236:280-96.
30. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat Rec 1993;236:297-313.
31. Karam SM, Leblond CP. Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behavior of entero-endocrine and caveolated cells: general conclusions of cell kinetics in the oxyntic epithelium. Anat Rec 1993;236:333-40.
32. Karam SM, Straiton T, Hassan WM, Leblond CP. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells 2003;21:322-36. (Pubitemid 36623174)
33. Ramsey VG, Doherty JM, Chen CC, Stappenbeck TS, Konieczny SF, Mills JC. The maturation of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic cells requires Mist1. Development 2007;134:211-22.
34. Nomura S, Baxter S, Yamaguchi T, Leys C, Vartapetian AB, Fox JG, et al. Spasmolytic polypeptide expressing metaplasia (SPEM) to pre-neoplasia in H. felis-infected mice. Gastroenterology 2004;127:582-94. (Pubitemid 39091906)
35. Nozaki K, Ogawa M, Williams JA, LaFleur BJ, Ng V, Drapkin RI, et al. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology 2008: 511-21. (Pubitemid 351173056)
36. Hirayama F, Takagi S, Kusuhara H, Iwao E, Yokoyama Y, Ikeda Y. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J Gastroenterol 1996;31:755-7. (Pubitemid 26345549)
37. Honda S, Fujioka T, Tokieda M, Gotoh T, Nishizono A, Nasu M. Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scand J Gastroenterol 1998;33:454-60. (Pubitemid 28277242)
38. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-8. (Pubitemid 28397299)
39. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998;58:4255-9. (Pubitemid 28450020)
40. Yoshizawa N, Takenaka Y, Yamaguchi H, Tetsuya T, Tanaka H, Tatematsu M, et al. Emergence of spasmolytic polypeptideexpressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest 2007;87:1265-76. (Pubitemid 350126706)
41. El-Zimaity HMT, Ramchatesingh J, Saeed MA, Graham DY. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 2001;54:679-83. (Pubitemid 32835414)
42. Sugimura T, Matsukura N, Sato S. Intestinal metaplasia of the stomach as a precancerous stage. IARC Sci Publ 1982: 515-30.
43. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-97. (Pubitemid 27157555)
44. Misra V, Misra S, Dwivedi M, Singh UP, Bhargava V, Gupta SC. A topographic study of Helicobacter pylori density, distribution and associated gastritis. J Gastroenterol Hepatol 2000;15:737-43. (Pubitemid 30615056)
45. Johnson LR. New aspects of the trophic actions of gastrointestinal hormones. Gastroenterology 1977;72:788-92.
46. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996;98:1918-29. (Pubitemid 26359210)
47. Zavros Y, Eaton KA, Kang W, Rathinavelu S, Katukuri V, Kao JY, et al. Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 2005;24:2354-66. (Pubitemid 40546694)
48. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking pS2 trefoil protein. Science 1996;274:259-62. (Pubitemid 26353205)
49. Judd LM, Alderman BM, Howlett M, Shulkes A, Dow C, Moverley J, et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 2004;126:196-207. (Pubitemid 38040736)
50. Andersson K, Chen D, Mattsson H, Sundler F, Hakanson R. Physiological significance of ECL-cell histamine. Yale J Biol Med 1998;71:183-93. (Pubitemid 29384189)
51. Chen D, Aihara T, Zhao CM, Hakanson R, Okabe S. Differentiation of the gastric mucosa. I. Role of histamine in control of function and integrity of oxyntic mucosa: understanding gastric physiology through disruption of targeted genes. Am J Physiol Gastrointest Liver Physiol 2006; 291: G539-44. (Pubitemid 44511671)
52. Hinkle KL, Samuelson LC. Lessons from genetically engineered animal models. III. Lessons learned from gastrin gene deletion in mice. Am J Physiol Gastrointest Liver Physiol 1999; 277: G500-5. (Pubitemid 29458221)
53. Jain RN, Samuelson LC. Differentiation of the gastric mucosa. II. Role of gastrin in gastric epithelial cell proliferation and maturation. Am J Physiol Gastrointest Liver Physiol 2006; 291: G762-5.
54. Lindstrom E, Chen D, Norlen P, Andersson K, Hakanson R. Control of gastric acid secretion: the gastrin-ECL cell-parietal cell axis. Comp Biochem Physiol A Mol Integr Physiol 2001;128:505-14. (Pubitemid 32200404)
55. Samuelson LC, Hinkle KL. Insights into the regulation of gastric acid secretion through analysis of genetically engineered mice. Annu Rev Physiol 2003;65:383-400.
56. Zimmerhackl B, Wunsch E, Classen M, Schusdziarra V, Schepp W. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept 1993;23:583-92. (Pubitemid 23208406)
57. Nozaki K, Weis V, Wang TC, Falus A, Goldenring JR. Altered gastric chief cell lineage differentiation in histamine-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1211-20.
58. Chew CS. Inhibitory action of somatostatin on isolated gastric glands and parietal cells. Am J Physiol Gastrointest Liver Physiol 1983; 245: G221-9.
59. Ogawa M, Nomura S, Varro A, Wang TC, Goldenring JR. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy. Am J Physiol Gastrointest Liver Physiol 2006; 290: G793-804.
60. Nam KT, Varro A, Coffey RJ, Goldenring JR. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulindeficient mice. Gastroenterology 2007;132:1804-19. (Pubitemid 46677950)
61. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47. (Pubitemid 30020371)
62. Mohammadi M, Czinn S, Redline R, Nedrud J. Helicobacterspecific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 1996;156:4729-38. (Pubitemid 26174457)
63. Roth KA, Kapadia SB, Martin SM, Lorenz RG. Cellular immune responses are essential for the development of Helicobacter felisassociated gastric pathology. J Immunol 1999;163:1490-7.
64. Houghton J, Stoicov C, Nomura S, Carlson J, Li H, Rogers AB, et al. Gastric cancer originating from bone marrow derived cells. Science 2004;306:1568-71. (Pubitemid 39564955)
65. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-8.
66. McDonald SA, Greaves LC, Gutierrez-Gonzalez L, Rodriguez-Justo M, Deheragoda M, Leedham SJ, et al. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology 2008;134:500-10. (Pubitemid 351173048)